<bill session="112" type="h" number="2674" updated="2023-01-11T13:22:41Z">
  <state datetime="2011-07-27">REFERRED</state>
  <status>
    <introduced datetime="2011-07-27"/>
  </status>
  <introduced datetime="2011-07-27"/>
  <titles>
    <title type="display">340B Program Improvement Act</title>
    <title type="official" as="introduced">To amend section 340B of the Public Health Service Act to improve the provision of discounts on drug purchases for certain safety net providers.</title>
    <title type="short" as="introduced">340B Program Improvement Act</title>
  </titles>
  <sponsor bioguide_id="M001159"/>
  <cosponsors>
    <cosponsor bioguide_id="B000911" joined="2011-07-27"/>
    <cosponsor bioguide_id="C001047" joined="2011-07-27"/>
    <cosponsor bioguide_id="C001060" joined="2011-12-01"/>
    <cosponsor bioguide_id="C001066" joined="2011-09-08"/>
    <cosponsor bioguide_id="C001085" joined="2011-07-27"/>
    <cosponsor bioguide_id="C001061" joined="2011-07-27"/>
    <cosponsor bioguide_id="C001068" joined="2011-11-29"/>
    <cosponsor bioguide_id="C001048" joined="2011-09-21"/>
    <cosponsor bioguide_id="C000984" joined="2011-12-01"/>
    <cosponsor bioguide_id="D000327" joined="2011-09-14"/>
    <cosponsor bioguide_id="E000172" joined="2011-07-27"/>
    <cosponsor bioguide_id="F000030" joined="2011-08-05"/>
    <cosponsor bioguide_id="G000410" joined="2012-02-28"/>
    <cosponsor bioguide_id="H001045" joined="2011-08-01"/>
    <cosponsor bioguide_id="H000329" joined="2011-11-01"/>
    <cosponsor bioguide_id="H001046" joined="2011-10-05"/>
    <cosponsor bioguide_id="H000636" joined="2012-02-14"/>
    <cosponsor bioguide_id="H001042" joined="2011-09-23"/>
    <cosponsor bioguide_id="J000292" joined="2011-11-16"/>
    <cosponsor bioguide_id="K000376" joined="2011-10-05"/>
    <cosponsor bioguide_id="K000210" joined="2011-07-29"/>
    <cosponsor bioguide_id="L000111" joined="2011-09-22"/>
    <cosponsor bioguide_id="L000553" joined="2011-09-08"/>
    <cosponsor bioguide_id="L000397" joined="2011-09-09"/>
    <cosponsor bioguide_id="L000576" joined="2011-10-12"/>
    <cosponsor bioguide_id="M000312" joined="2012-04-18"/>
    <cosponsor bioguide_id="N000184" joined="2012-02-14"/>
    <cosponsor bioguide_id="O000169" joined="2011-07-27"/>
    <cosponsor bioguide_id="P000601" joined="2011-11-17"/>
    <cosponsor bioguide_id="P000258" joined="2011-09-08"/>
    <cosponsor bioguide_id="R000515" joined="2011-07-27"/>
    <cosponsor bioguide_id="S001145" joined="2011-12-01"/>
    <cosponsor bioguide_id="S001157" joined="2011-09-13"/>
    <cosponsor bioguide_id="S001148" joined="2011-07-29"/>
    <cosponsor bioguide_id="S000480" joined="2011-12-01"/>
    <cosponsor bioguide_id="T000467" joined="2011-10-12"/>
    <cosponsor bioguide_id="T000463" joined="2011-12-01"/>
    <cosponsor bioguide_id="W000800" joined="2011-11-03"/>
    <cosponsor bioguide_id="Y000031" joined="2011-07-27"/>
  </cosponsors>
  <actions>
    <action datetime="2011-07-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2011-07-27" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-07-27">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2011-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2011-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="112" type="h" number="5194" relation="unknown"/>
    <bill session="112" type="h" number="5624" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Health care costs and insurance"/>
    <term name="Health facilities and institutions"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2011-09-15T14:54:37Z" status="Introduced in House">340B Program Improvement Act - Amends the Public Health Service Act to make revisions to the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees).

Includes drugs used in connection with an inpatient or outpatient service by enrolled hospitals as covered drugs under the program (currently, only outpatient drugs are covered under the program).

Requires hospitals enrolled in the 340B program to provide to each state a credit on the estimated annual purchases by such hospitals of covered drugs provided to Medicaid recipients for inpatient use. Sets forth a formula for calculating the credit. Allows a hospital to avoid paying such credits under certain circumstances.

Eliminates the requirement that hospitals enrolled in the 340B program report the National Drug Code numbers for drugs administered by a physician if the state is precluded from seeking a rebate on such drugs because they were purchased at a discount under the 340B program.

Removes the exclusion that prohibited covered entities added to the 340B program under the Patient Protection and Affordable Care Act from purchasing drugs for a rare disease or condition as covered outpatient drugs.

Treats a facility or organization that is eligible for the 340B program as satisfying any geographic location requirements in relation to a hospital or a critical access hospital for purposes of determining provider-based status under Medicare.</summary>
</bill>
